Oswald Bloemen

1.3k total citations
29 papers, 797 citations indexed

About

Oswald Bloemen is a scholar working on Molecular Biology, Cognitive Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Oswald Bloemen has authored 29 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cognitive Neuroscience and 9 papers in Psychiatry and Mental health. Recurrent topics in Oswald Bloemen's work include Congenital heart defects research (9 papers), Schizophrenia research and treatment (9 papers) and Functional Brain Connectivity Studies (6 papers). Oswald Bloemen is often cited by papers focused on Congenital heart defects research (9 papers), Schizophrenia research and treatment (9 papers) and Functional Brain Connectivity Studies (6 papers). Oswald Bloemen collaborates with scholars based in Netherlands, United Kingdom and Ireland. Oswald Bloemen's co-authors include Thérèse van Amelsvoort, Mariken B. de Koning, Don Linszen, Lieuwe de Haan, Dorien H. Nieman, Declan Murphy, Kieran C. Murphy, Eileen Daly, Hiske E. Becker and Jan Booij and has published in prestigious journals such as PLoS ONE, The British Journal of Psychiatry and Psychological Medicine.

In The Last Decade

Oswald Bloemen

29 papers receiving 788 citations

Peers

Countries citing papers authored by Oswald Bloemen

Since Specialization

Citations

This map shows the geographic impact of Oswald Bloemen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oswald Bloemen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oswald Bloemen more than expected).

Fields of papers citing papers by Oswald Bloemen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oswald Bloemen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oswald Bloemen. The network helps show where Oswald Bloemen may publish in the future.

Co-authorship network of co-authors of Oswald Bloemen

This figure shows the co-authorship network connecting the top 25 collaborators of Oswald Bloemen. A scholar is included among the top collaborators of Oswald Bloemen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oswald Bloemen. Oswald Bloemen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The muscarinic M1 receptor modulates associative learning and memory in psychotic disorders 2020 ·NeuroImage Clinical ·Geor Bakker, Claudia Vingerhoets, Oswald Bloemen, Barbara J. Sahakian, Jan Booij, Matthan W.A. Caan, Thérèse van Amelsvoort	7
2	Low prevalence of substance use in people with 22q11.2 deletion syndrome 2019 ·The British Journal of Psychiatry ·Claudia Vingerhoets, (unknown), Oswald Bloemen, Erik Boot, (unknown), L. J. M. Evers, Ania Fiksinski, Elemi Breetvelt, (unknown), Elfi Vergaelen, Annick Vogels, Carin J. Meijer, Jan Booij, (unknown), L. de Haan, Ann Swillen, Jacob Vorstman, Anne S. Bassett, Thérèse van Amelsvoort	12
3	Relationship between muscarinic M1 receptor binding and cognition in medication-free subjects with psychosis 2018 ·NeuroImage Clinical ·Geor Bakker, Claudia Vingerhoets, (unknown), Matthan W.A. Caan, Oswald Bloemen, Jos Eersels, Jan Booij, Thérèse van Amelsvoort	36
4	Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia 2018 ·The Journal of Clinical Psychiatry ·(unknown), (unknown), Ritsaert Lieverse, Margreet Oorschot, Wolfgang Viechtbauer, Oswald Bloemen, Peter N. van Harten	38
5	The effect of the muscarinic M 1 receptor antagonist biperiden on cognition in medication free subjects with psychosis 2017 ·European Neuropsychopharmacology ·Claudia Vingerhoets, Geor Bakker, (unknown), Oswald Bloemen, Ya Wang, Raymond C. K. Chan, Jan Booij, Thérèse van Amelsvoort	15
6	Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis 2017 ·Psychiatry Research Neuroimaging ·Claudia Vingerhoets, Oswald Bloemen, Erik Boot, Geor Bakker, Mariken B. de Koning, Fabiana da Silva Alves, Jan Booij, Thérèse van Amelsvoort	8
7	Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome 2016 ·PLoS ONE ·Geor Bakker, Matthan W.A. Caan, (unknown), (unknown), (unknown), Erik Boot, Dorien H. Nieman, Lieuwe de Haan, Oswald Bloemen, Jan Booij, Thérèse van Amelsvoort	20
8	Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis 2016 ·Psychological Medicine ·Geor Bakker, Matthan W.A. Caan, Renée S. Schluter, Oswald Bloemen, (unknown), Mariken B. de Koning, Erik Boot, (unknown), Dorien H. Nieman, Lieuwe de Haan, Jan Booij, Thérèse van Amelsvoort	20
9	PRODH rs450046 and proline x COMT Val158Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome 2015 ·Psychopharmacology ·Mariken B. de Koning, (unknown), Erik Boot, Oswald Bloemen, Jaap Bakker, Kathryn M. Abel, Thérèse van Amelsvoort	12
10	¹²³I-Iododexetimide Preferentially Binds to the Muscarinic Receptor Subtype M₁In Vivo 2015 ·Journal of Nuclear Medicine ·Geor Bakker, (unknown), (unknown), Kora de Bruin, Jos Eersels, Jan de Jong, (unknown), Bart P. F. Rutten, Susan L. DuBois, (unknown), Adrian J. Mogg, (unknown), Michael Crabtree, David Collier, Christian C. Felder, Vanessa Barth, Lisa M. Broad, Oswald Bloemen, Thérèse A. van Amelsvoort, Jan Booij	18
11	Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis 2014 ·Journal of Psychopharmacology ·Mariken B. de Koning, Oswald Bloemen, (unknown), Jan Booij, Kathryn M. Abel, Lieuwe de Haan, Don Linszen, Thérèse A. van Amelsvoort	23
12	Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What’s the Evidence? 2013 ·Frontiers in Psychiatry ·(unknown), Oswald Bloemen, Geor Bakker, Thérèse van Amelsvoort	33
13	Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis 2012 ·European Neuropsychopharmacology ·Oswald Bloemen, Mariken B. de Koning, Tobias Gleich, (unknown), Lieuwe de Haan, Don Linszen, Jan Booij, Thérèse van Amelsvoort	30
14	White matter abnormalities in adults with 22q11 deletion syndrome with and without schizophrenia 2011 ·Schizophrenia Research ·Fabiana da Silva Alves, Nicole Schmitz, Oswald Bloemen, J. van der Meer, (unknown), Erik Boot, Aart J. Nederveen, Lieuwe de Haan, Don Linszen, Thérèse van Amelsvoort	33
15	White matter microstructure in 22q11 deletion syndrome: a pilot diffusion tensor imaging and voxel-based morphometry study of children and adolescents 2010 ·Journal of Neurodevelopmental Disorders ·Frederick Sundram, Linda Campbell, Rayna Azuma, Eileen Daly, Oswald Bloemen, Gareth J. Barker, Xavier Chitnis, Derek K. Jones, Thérèse van Amelsvoort, Kieran C. Murphy, Declan Murphy	36
16	White matter integrity in Asperger syndrome: a preliminary diffusion tensor magnetic resonance imaging study in adults 2010 ·Autism Research ·Oswald Bloemen, Quinton Deeley, Frederick Sundram, Eileen Daly, Gareth J. Barker, Derek K. Jones, Thérèse van Amelsvoort, Nicole Schmitz, Dene Robertson, Kieran C. Murphy, Declan Murphy	63
17	Clinical and anatomical heterogeneity in autistic spectrum disorder: a structural MRI study 2009 ·Psychological Medicine ·Fiona Toal, Eileen Daly, Lisa Page, Quinton Deeley, Brian Hallahan, Oswald Bloemen, William J. Cutter, Michael Brammer, Sarah Curran, Dene Robertson, Clodagh M. Murphy, Kieran C. Murphy, Declan Murphy	92
18	Early intervention in patients at ultra high risk of psychosis: benefits and risks 2009 ·Acta Psychiatrica Scandinavica ·Mariken B. de Koning, Oswald Bloemen, Thérèse van Amelsvoort, Hiske E. Becker, Dorien H. Nieman, Mark van der Gaag, Don Linszen	60
19	Psychosis and autism: magnetic resonance imaging study of brain anatomy 2009 ·The British Journal of Psychiatry ·Fiona Toal, Oswald Bloemen, Quinton Deeley, Nigel Tunstall, Eileen Daly, Lisa Page, Michael Brammer, Kieran C. Murphy, Declan Murphy	58
20	White-matter markers for psychosis in a prospective ultra-high-risk cohort 2009 ·Psychological Medicine ·Oswald Bloemen, Mariken B. de Koning, Nicole Schmitz, Dorien H. Nieman, Hiske E. Becker, Lieuwe de Haan, Peter Dingemans, Don Linszen, Thérèse van Amelsvoort	117

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact